CN115315242A - 透明质酸产生促进剂 - Google Patents

透明质酸产生促进剂 Download PDF

Info

Publication number
CN115315242A
CN115315242A CN202180023440.7A CN202180023440A CN115315242A CN 115315242 A CN115315242 A CN 115315242A CN 202180023440 A CN202180023440 A CN 202180023440A CN 115315242 A CN115315242 A CN 115315242A
Authority
CN
China
Prior art keywords
hyaluronic acid
magnesium
production
skin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180023440.7A
Other languages
English (en)
Chinese (zh)
Inventor
新妻真纪子
胜田雄治
五十里彰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of CN115315242A publication Critical patent/CN115315242A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
CN202180023440.7A 2020-04-22 2021-04-20 透明质酸产生促进剂 Pending CN115315242A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020076345 2020-04-22
JP2020-076345 2020-04-22
PCT/JP2021/016058 WO2021215440A1 (ja) 2020-04-22 2021-04-20 ヒアルロン酸産生促進剤

Publications (1)

Publication Number Publication Date
CN115315242A true CN115315242A (zh) 2022-11-08

Family

ID=78269414

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180023440.7A Pending CN115315242A (zh) 2020-04-22 2021-04-20 透明质酸产生促进剂

Country Status (3)

Country Link
JP (1) JP7832104B2 (https=)
CN (1) CN115315242A (https=)
WO (1) WO2021215440A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026003274A1 (en) * 2024-06-28 2026-01-02 Unilever Ip Holdings B.V. Skin care benefit cosmetic compositions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006204260A (ja) * 2005-01-31 2006-08-10 Toyobo Co Ltd ヒアルロン酸合成酵素及びその遺伝子
US20070092469A1 (en) * 2005-10-26 2007-04-26 Eric Jacobs Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
US20080138865A1 (en) * 2006-07-06 2008-06-12 Reliance Life Sciences Pvt. Ltd. Optimisation of culture conditions for production and process of purification of high molecular weight hyaluronic acid
JP2012001457A (ja) * 2010-06-15 2012-01-05 Toyo Beauty Kk 抗しわ剤および抗老化性化粧料
CN103908415A (zh) * 2014-04-18 2014-07-09 美晨集团股份有限公司 一种面膜及其制备方法
CN108719998A (zh) * 2017-04-24 2018-11-02 中南大学湘雅医院 一种用于治疗骨关节炎的口服膳食补充药剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08183708A (ja) * 1994-12-28 1996-07-16 Osaka Yakuhin Kenkyusho:Kk しみ・くすみ除去化粧料組成物
DE60236688D1 (de) * 2001-06-13 2010-07-22 Univ Oklahoma State Hyaluronansynthase-gene und expression davon
JP2004075629A (ja) * 2002-08-21 2004-03-11 Kanebo Ltd 化粧料
JP4425554B2 (ja) * 2003-03-19 2010-03-03 日本メナード化粧品株式会社 皮膚外用剤
US20080038219A1 (en) * 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
JP2010013378A (ja) * 2008-07-02 2010-01-21 Mandom Corp 皮膚外用剤組成物
JP2010037287A (ja) * 2008-08-06 2010-02-18 Kaneka Corp 還元型補酵素ｑ及びｎ−アセチルグルコサミン含有組成物
CN101935679A (zh) * 2010-03-04 2011-01-05 上海交通大学 基于革兰氏阳性安全微生物的透明质酸的异源合成方法
JP2011190286A (ja) * 2010-03-11 2011-09-29 Yokohama Rubber Co Ltd:The ホットメルト接着剤組成物
JP2011190186A (ja) * 2010-03-12 2011-09-29 Nicca Chemical Co Ltd アクアポリン３産生促進剤、及びそれを含有する化粧料
JP6208066B2 (ja) * 2014-03-31 2017-10-04 富士フイルム株式会社 組成物、皮膚外用剤、化粧料、及び飲食品

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006204260A (ja) * 2005-01-31 2006-08-10 Toyobo Co Ltd ヒアルロン酸合成酵素及びその遺伝子
US20070092469A1 (en) * 2005-10-26 2007-04-26 Eric Jacobs Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
US20080138865A1 (en) * 2006-07-06 2008-06-12 Reliance Life Sciences Pvt. Ltd. Optimisation of culture conditions for production and process of purification of high molecular weight hyaluronic acid
JP2012001457A (ja) * 2010-06-15 2012-01-05 Toyo Beauty Kk 抗しわ剤および抗老化性化粧料
CN103908415A (zh) * 2014-04-18 2014-07-09 美晨集团股份有限公司 一种面膜及其制备方法
CN108719998A (zh) * 2017-04-24 2018-11-02 中南大学湘雅医院 一种用于治疗骨关节炎的口服膳食补充药剂

Also Published As

Publication number Publication date
JP7832104B2 (ja) 2026-03-17
JPWO2021215440A1 (https=) 2021-10-28
WO2021215440A1 (ja) 2021-10-28

Similar Documents

Publication Publication Date Title
US9211244B2 (en) Method for anti-skin aging using caffeamide derivative
EP3288531B1 (en) Method of improving skin health and compositions therefor
KR102187618B1 (ko) 수크로스, 인돌-3-아세트산 및 로즈힙 열매 추출물의 혼합물을 포함하는 피부 외용제 조성물
Chang et al. Evaluation of the protective effects of chondroitin sulfate oligosaccharide against osteoarthritis via inactivation of NLRP3 inflammasome by in vivo and in vitro studies
KR101136742B1 (ko) 연산호류 추출물 및 그것의 용도
US11213472B2 (en) VEGFC production promoter
JP7832104B2 (ja) ヒアルロン酸産生促進剤
JP2017014205A (ja) トリプターゼ阻害剤組成物
JP7082827B2 (ja) 化粧料
WO2020255989A1 (ja) スイカ由来の新規化合物とそれを用いた組成物
KR20200092669A (ko) 인진쑥 발효물을 포함하는 피부 기능성 조성물
JP2011126814A (ja) コラーゲン産生促進剤、ヒアルロン酸産生促進剤、並びにコラーゲン産生促進およびヒアルロン酸産生促進剤
KR101936689B1 (ko) Ａｒｐ１０１을 포함하는 피부 미백용 조성물
JPWO2022168846A5 (https=)
KR20100059305A (ko) 저실자 추출물 함유 피부외용제 조성물
JP2009161476A (ja) インテグリン、ビンキュリン促進剤及びナトリウム依存性ビタミンｃ輸送体（ｓｖｃｔ２）の発現促進剤
TW202038903A (zh) 複方精油組合物用於調控ｍｍｐ基因、ｍｃ１ｒ基因、ｋｒｔ基因、ｔｅｒｔ基因、ｔｅｒｃ基因、及／或ｏｇｇ１基因表現量的用途
JP2020125247A (ja) アクアポリン発現促進剤
WO2022173012A1 (ja) スペルミジン産生促進剤
KR101519654B1 (ko) 슬리밍용 조성물
JP2019052114A (ja) コラーゲン産生促進剤及びコラーゲン産生促進用食品
KR20260024519A (ko) 화이트토마토 추출물을 포함하는 반려동물 눈물 착색 억제 및 피모 케어용 조성물
KR102645432B1 (ko) 피부 세포 분화 촉진용 조성물 및 피부 세포 분화 촉진 물질의 스크리닝 방법
KR20260003504A (ko) 동백나무씨오일, 코코넛야자오일, 또는 이들의 혼합물을 포함하는 반려동물 눈물 착색 억제 및 피모 케어용 조성물
KR20240165441A (ko) 콜라겐 산생 촉진제, 화장료 조성물 또는 피부 외용제 및 경구 투여제

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination